Results 211 to 220 of about 276,776 (266)

PROteolysis TArgeting Chimera (PROTAC) Estrogen Receptor Degraders for Treatment of Estrogen Receptor-Positive Advanced Breast Cancer. [PDF]

Target Oncol
Hamilton EP, Jeselsohn RM, Vahdat LT, Hurvitz SA.   +3 more
europepmc   +1 more source

Estrogen Receptor-Low Positive (ER-Low) Breast Cancer: A Unique Clinical and Pathological Entity. [PDF]

Curr Oncol
Faa G, Lai E, Ziranu P, Pretta A, Tiwari E, Dessì M, Solinas C, Saba G, Loi F, Codipietro C, Graziano S, Ottelio L, Dessena M, Coghe F, Suri JS, Saba L, Scartozzi M.   +16 more
europepmc   +1 more source

Mutant p53 binds and controls estrogen receptor activity to drive endocrine resistance in ovarian cancer. [PDF]

Genes Dev
Shao C, Indeglia A, Foster M, Casey K, Leung J, Modarai SR, Leu JI, Duong B, Mes-Masson AM, Sims-Mourtada J, Auslander N, Drapkin R, Bitler BG, Zhang N, Murphy ME.   +14 more
europepmc   +1 more source

Study of Estrogen Receptor Alpha Gene Polymorphisms (<i>ERα</i>, <i>ESR1</i>) in Women with Ovarian Cancer. [PDF]

Int J Mol Sci
Łukasiewicz H, Samulak D, Romanowicz H, Smolarz B.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Estrogens, estrogen receptors and melanoma

Expert Review of Anticancer Therapy, 2011
The skin is the largest nonreproductive target tissue on which estrogen plays many beneficial and protective roles. Although neither exogenous hormones nor pregnancy represent significant risk factors for melanoma, epidemiological data suggest a higher survival rate in women with metastatic disease versus men and in premenopausal versus postmenopausal ...
Vincenzo De Giorgi, GORI, ALESSIA, Marta Grazzini, Susanna Rossari, Federica Scarf?, Suzanna Corciova, Alice Verdelli, Torello Lotti, MASSI, DANIELA   +8 more
openaire   +3 more sources

The Role of Estrogen and Estrogen Receptors in Chemoresistance

Current Medicinal Chemistry, 2011
Drug resistance is one of the major obstacles limiting the success of cancer chemotherapy. Biological mechanisms contributing to drug resistance may be present de novo and related to inherent features or may be raised after exposure to anticancer drugs. In recent years, both clinical observations and experimental studies suggested that steroid hormones
M, Sui, H, Zhang, W, Fan
openaire   +2 more sources

Biological Role of Estrogen and Estrogen Receptors

Critical Reviews in Biochemistry and Molecular Biology, 2002
(2002). Biological Role of Estrogen and Estrogen Receptors. Critical Reviews in Biochemistry and Molecular Biology: Vol. 37, No. 1, pp. 1-28.
Stefan, Nilsson, Jan-Ake, Gustafsson
openaire   +2 more sources

Estrogen and estrogen receptors in thyroid carcinomas

Journal of Surgical Oncology, 1991
AbstractThyroid tissues, composed of normal thyroid (10 cases), Graves' thyroid (4), and papillary carcinoma (10), were measured for the presence of receptors for estrogen (ER) using an enzyme‐immunoassay method. The mean value of ER in papillary carcinoma tissues (4.0 ± 3.6 fmol/mg protein) was higher than that in normal thyroid tissues (0.8 ± 0.4 ...
Y, Mizukami, T, Michigishi, A, Nonomura, T, Hashimoto, M, Noguchi, F, Matsubara   +5 more
openaire   +2 more sources